These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 18622421

  • 1. Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
    Costa LJ, Rodriguez V, Porrata LF, Lacy MQ, Elliott MA, Gertz MA, Gastineau DA, Litzow MR.
    Bone Marrow Transplant; 2008 Oct; 42(7):497-8. PubMed ID: 18622421
    [No Abstract] [Full Text] [Related]

  • 2. Translocation (X;10) in a child with therapy-related acute myeloid leukemia following chemotherapy for Ewing's Sarcoma.
    Abla O, Dror Y, Shago M.
    Cancer Genet Cytogenet; 2007 Oct 15; 178(2):168-9. PubMed ID: 17954276
    [No Abstract] [Full Text] [Related]

  • 3. Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.
    Waterman J, Rybicki L, Bolwell B, Copelan E, Pohlman B, Sweetenham J, Dean R, Sobecks R, Andresen S, Kalaycio M.
    Bone Marrow Transplant; 2012 Apr 15; 47(4):488-93. PubMed ID: 21572461
    [Abstract] [Full Text] [Related]

  • 4. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.
    Carney DA, Westerman DA, Tam CS, Milner A, Prince HM, Kenealy M, Wolf M, Januszewicz EH, Ritchie D, Came N, Seymour JF.
    Leukemia; 2010 Dec 15; 24(12):2056-62. PubMed ID: 20962860
    [Abstract] [Full Text] [Related]

  • 5. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis.
    Forrest DL, Nevill TJ, Naiman SC, Le A, Brockington DA, Barnett MJ, Lavoie JC, Nantel SH, Song KW, Shepherd JD, Sutherland HJ, Toze CL, Davis JH, Hogge DE.
    Bone Marrow Transplant; 2003 Nov 15; 32(9):915-23. PubMed ID: 14561993
    [Abstract] [Full Text] [Related]

  • 6. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
    Au WY, Chan LC, Liang R, Kwong YL.
    Am J Hematol; 2006 Jun 15; 81(6):471-3. PubMed ID: 16680740
    [No Abstract] [Full Text] [Related]

  • 7. Myeloablative therapy, stem cell rescue and gene transfer in advanced Ewing tumors.
    Burdach S, Nürnberger W, Laws HJ, Engel BC, Dirksen U, Krauth K, Pape H, Kahn T, Körholz D, Gadner H, Göbel U, Jürgens H.
    Bone Marrow Transplant; 1996 Sep 15; 18 Suppl 1():S67-8. PubMed ID: 8899179
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.
    Arana-Yi C, Block AW, Sait SN, Ford LA, Barcos M, Baer MR.
    Leuk Res; 2008 Jul 15; 32(7):1043-8. PubMed ID: 18093651
    [Abstract] [Full Text] [Related]

  • 11. Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?
    Hake CR, Graubert TA, Fenske TS.
    Bone Marrow Transplant; 2007 Jan 15; 39(2):59-70. PubMed ID: 17143301
    [Abstract] [Full Text] [Related]

  • 12. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.
    Kollmannsberger C, Hartmann JT, Kanz L, Bokemeyer C.
    J Cancer Res Clin Oncol; 1998 Jan 15; 124(3-4):207-14. PubMed ID: 9619748
    [Abstract] [Full Text] [Related]

  • 13. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
    Friedberg JW.
    Haematologica; 2008 Mar 15; 93(3):336-8. PubMed ID: 18310538
    [No Abstract] [Full Text] [Related]

  • 14. Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation.
    Fenk R, Neubauer F, Bruns I, Schröder T, Germing U, Haas R, Kobbe G.
    Br J Haematol; 2012 Mar 15; 156(5):683-6. PubMed ID: 22050384
    [No Abstract] [Full Text] [Related]

  • 15. Therapy for metastatic ESFT: is it time to ask new questions?
    Snyder KM, Mackall CL.
    Pediatr Blood Cancer; 2007 Aug 15; 49(2):115-6. PubMed ID: 17474114
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Philadelphia chromosome-positive acute lymphoblastic leukemia secondary to chemoradiotherapy for Ewing sarcoma. Report of two cases and concise review of the literature.
    Snyder DS, Stein AS, O'Donnell MR, Gaal K, Slovak ML, Forman SJ.
    Am J Hematol; 2005 Jan 15; 78(1):74-8. PubMed ID: 15609284
    [Abstract] [Full Text] [Related]

  • 18. Porphyria cutanea tarda in a patient with post-transplant MDS.
    Oubre D, Cruz J, Keung Y.
    Bone Marrow Transplant; 2001 Jan 15; 27(2):219-20. PubMed ID: 11281395
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.